328: Pfizer's activist troubles, gene therapy questions, RFK Jr.'s MAHA ambitions

Joining the discussion is Sarah Overmal, a STAT DC reporter, who dives into the intriguing world of Robert F. Kennedy Jr. and his Make America Healthy Again movement. They explore the controversial challenges faced by Pfizer, particularly regarding an activist investor's campaign. The conversation also raises important questions about gene therapy approvals for Duchenne muscular dystrophy. Additionally, they navigate the complex dynamics of Novo Holdings in a significant acquisition scenario, reflecting on the broader implications for the future of healthcare.